DocDollars

Baudax Bio Inc.

PA · United States · Reporting entity ID 100000646811

Total reported 2019–2025
$2.69M
#922 of 2,960 reporting companies — 0% of all reported industry payments
$712K in general payments across 6,359 records, plus $1.98M in research funding across 57 records.

How it breaks down

General payments $712,352
Research funding $1,977,780

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Baudax Bio Inc. reported $2.69M to US doctors and teaching hospitals from 2019 to 2025, ranking #922 of 2,960 reporting companies. 74% of that was research funding and 26% general payments such as consulting, speaking, food and travel. 6,359 general payment records and 57 research records were filed.

Common questions about Baudax Bio Inc.

How much has Baudax Bio Inc. paid US doctors?

Baudax Bio Inc. reported $2,690,132 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $712,352 in general payments, $1,977,780 in research funding.

How does Baudax Bio Inc. rank among drug and device companies?

It ranks #922 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Baudax Bio Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.